• / Free eNewsletters & Magazine
  • / My Account
Home>Finance>Securities Litigation Reform Act

Securities Litigation Reform Act

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Gilead Expands Hepatitis C Generic Licensing Agreements to Include Investigational Pan-Genotypic Agent

    Gilead Expands Hepatitis C Generic Licensing Agreements to Include Investigational Pan-Genotypic Agent

  2. Regeneron and Sanofi Announce Praluent™ (alirocumab) Biologics License Application has Been Accepted for Priority Review by US FDA

    Regeneron and Sanofi Announce Praluentâ„¢ (alirocumab) Biologics License Application has Been Accepted for Priority Review by US FDA

  3. Healthways Board Exploring Strategic Alternatives to Enhance Shareholder Value

    Healthways Board Exploring Strategic Alternatives to Enhance Shareholder Value

  4. Republic Bank Opens New Store in Glassboro, N.J.

    Republic Bank Opens New Store in Glassboro, N.J.

  5. Dealertrack Receives Several AWA Honors for Excellence in Automotive Digital Marketing at NADA 2015

    Dealertrack Receives Several AWA Honors for Excellence in Automotive Digital Marketing at NADA 2015

  6. LoJack and Novatel Wireless to Develop New Inventory Management Products for the Automotive Market

    LoJack and Novatel Wireless to Develop New Inventory Management Products for the Automotive Market

  7. GFI Group Reschedules Special Meeting of GFI Stockholders to Allow Stockholders Additional Time to Review Additional Disclosures

    GFI Group Reschedules Special Meeting of GFI Stockholders to Allow Stockholders Additional Time to Review Additional Disclosures

  8. IDEXX Laboratories to Release 2014 Fourth Quarter and Full-Year Financial Results

    IDEXX Laboratories to Release 2014 Fourth Quarter and Full-Year Financial Results

  9. Century Next Financial Corporation Reports Yearend Results

    Century Next Financial Corporation Reports Yearend Results

  10. BIND Therapeutics Amends Credit Facility from Hercules Technology III, L.P. to Accelerate Accurin Pipeline Growth

    BIND Therapeutics Amends Credit Facility from Hercules Technology III, L.P. to Accelerate Accurin Pipeline Growth

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.